Common Contracts
5 similar Offer Letter contracts by Curis Inc
AMENDMENT TO OFFER LETTEROffer Letter • June 4th, 2010 • Curis Inc • Biological products, (no disgnostic substances) • Delaware
This Amendment (the “Amendment”), effective as of June 3, 2010 (the “Effective Date”), to the offer letter dated March 21, 2008 (the “Offer Letter”) by and between Curis, Inc., a Delaware corporation (the “Company”), and Dr. Mitchell Keegan (the “Executive”).
AMENDMENT TO OFFER LETTEROffer Letter • March 14th, 2008 • Curis Inc • Biological products, (no disgnostic substances) • Delaware
This Amendment (the “Amendment”), effective as of December 14, 2006 (the “Effective Date”), to the offer letter dated May 2, 2001, as amended by the promotion letter dated May 10, 2002 (collectively, the “Offer Letter”), by and between Curis, Inc., a Delaware corporation (the “Company”), and Changgeng Qian (the “Executive”).
AMENDMENT TO OFFER LETTEROffer Letter • November 2nd, 2006 • Curis Inc • Biological products, (no disgnostic substances) • Delaware
This Amendment (the “Amendment”), effective as of October 31, 2006 (the “Effective Date”), to the offer letter dated January 11, 2001 (the “Offer Letter”) by and between Curis, Inc., a Delaware corporation (the “Company”), and Mark W. Noel (the “Executive”).
AMENDMENT TO OFFER LETTEROffer Letter • November 2nd, 2006 • Curis Inc • Biological products, (no disgnostic substances) • Delaware
This Amendment (the “Amendment”), effective as of October 31, 2006 (the “Effective Date”), to the offer letter dated July 25, 2002 (the “Offer Letter”) by and between Curis, Inc., a Delaware corporation (the “Company”), and Mary Elizabeth Potthoff (the “Executive”).
AMENDMENT TO OFFER LETTEROffer Letter • November 2nd, 2006 • Curis Inc • Biological products, (no disgnostic substances) • Delaware
This Amendment (the “Amendment”), effective as of October 31, 2006 (the “Effective Date”), to the offer letter dated December 10, 2003 (the “Offer Letter”) by and between Curis, Inc., a Delaware corporation (the “Company”), and Michael P. Gray (the “Executive”).
